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Discussion

Introduction
Coronary artery ectasia (CAE) is diffuse dilatation exceeding more
than 1/3 the coronary artery length and diameter exceeding the
adjacent reference segments by 1.5 times. CAE is found incidentally
on diagnostic coronary angiography with incidences of 1.4 to 4.9%
and is an uncommon cause of acute coronary syndrome (ACS). The
most common etiology is atherosclerosis, but could be congenital or
secondary to sequela or vasculitic coronary disorders. These ectatic
segments may serve as a nidus for thrombus formation with
possibility of distal embolization. Thus, patients with CAE have
worse outcomes than the general population. Due to the stagnant
non-laminar flow associated with these segments, anticoagulation
has been recommended for larger caliber aneurysms on the basis of
an increased risk of thrombosis and myocardial infarction that is not
related to plaque rupture. However, the benefits of anticoagulation
must outweigh the risk of bleeding.

Figure 1: Coronary angiographic image of ectatic segments in the proximal and mid Left
circumflex coronary artery (LCx)

1. Distinguish coronary ectasia in the realm of aneurysmal
coronary disease
2. Discuss how the management of coronary ectasia often poses a
significant challenge

Case description
78 y/o Ecuadorian female with history of hypertension, dyslipidemia
and prior inferior MI treated initially with balloon angioplasty in
South America followed by RCA stent in 2014 presented with
worsening typical chest pain. Radiating to her left arm and
associated with exercise for the last 6 months. Medications included
aspirin, atenolol, hydralazine and atorvastatin. No history of febrile
childhood illness suggestive of Kawasaki disease. Admits to social
tobacco use. Denied alcohol or illicit drug use.
On initial assessment, patient was in no acute distress. Vital signs
were stable. On exam, regular heart sounds, no jugular venous
distention or lower extremity edema was noted. Peak troponin I
elevated at 2.9 ng/mL. EKG showed a right bundle branch block with
nonspecific ST segment and T wave changes. Q waves were noted in
the inferior leads. Echocardiogram revealed normal LV function,
with an ejection fraction of 60% with no valvular disease. Coronary
angiography revealed 90% stenosis of the posterior descending
artery (PDA), with dilation and severe ectasia affecting multiple
major vessels (LMCA, LAD, LCx, RCA). A drug eluting stent was
deployed to relieve the stenosis in the PDA.

Treatment options for CAE include risk-factor modification, dual
anti-platelet therapy (DAPT) and antithrombotic therapy.
Anticoagulation therapy to prevent coronary thrombus formation
has been a controversial topic because of limited randomized trials
demonstrating its benefit in CAE. The therapeutic decision should
be focused on how to reduce the heavy thrombus burden to
improve coronary flow. If the patient’s response to standard DAPT is
inadequate, then warfarin or novel oral anticoagulation (NOACs)
may provide an alternative in combination with DAPT. In this case of
Type I coronary artery ectasia the patient was deemed not to be
high risk for recurrent thrombosis and stenosis. She was placed on
aspirin and clopidogrel. The treatment of CAE is a vexing clinical
question and the decision to anticoagulate must be made on an
individual basis based on thrombosis VS bleeding risk until further
studies are done to evaluate the clinical efficacy of this strategy.

Figure 2: Coronary angiographic image of ectatic segments in the proximal and mid
right coronary artery (RCA)

Definition
Classification
Involved
Segment
Etiology

Ectasia (CAE)
Diffuse Dilatation
(>1/3)
Types I-IV

Aneurysm (CAA)
Focal Dilatation
(<1/3)
Saccular VS
Fusiform
RCA, LCx (least LAD) LAD, RCA

AS, Vasculitis, CT
AS, Kawasaki,
disorders
Mycotic, Cocaine
Complications Rupture, thrombosis, embolization,
fistula, tamponade
Treatment
Conservative: ASA + AC
Surgery/PCI

Table 1: Distinguishing coronary artery ectasia (CAE) from coronary artery aneurysm (CAA)
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Figure 3: Illustration of CAA VS CAE
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